Pricing Log in Create free account

DBV Technologies S.A. (DBVT) vs Silence Therapeutics PLC Sponsored ADR (SLN)

DBV Technologies S.A. and Silence Therapeutics PLC Sponsored ADR are both Biotechnology companies. DBV Technologies S.A. and Silence Therapeutics PLC Sponsored ADR are of similar size ($581.1M and $572.6M). DBV Technologies S.A. grew revenue faster over the last twelve months: 27.1% against −97.0%. Silence Therapeutics PLC Sponsored ADR has the higher net margin (0.00% vs −3,564.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Silence Therapeutics PLC Sponsored ADR leads on 9 and DBV Technologies S.A. on 7.

Valuation

Metric DBVT SLN Biotechnology median
P/E n/m n/m 8.50
P/S 158.97 488.70 9.71
P/B 4.89 10.66 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 123.58 402.90 9.21
Earnings yield (38.78%) (14.75%) (33.15%)
Free cash flow yield (21.74%) (10.32%) (25.50%)

Profitability

Metric DBVT SLN Biotechnology median
Gross margin 100.00% 79.50% 65.16%
Operating margin (3,601.22%) 0.00% 0.00%
Net margin (3,564.57%) 0.00% 0.00%
Free cash flow margin (3,456.50%) 0.00% 0.00%
Return on equity (142.63%) (90.41%) (56.36%)
Return on assets (95.98%) (44.14%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DBVT SLN Biotechnology median
Revenue growth (TTM) 27.12% (96.97%) 6.02%
EPS growth (last fiscal year) 10.26% (90.91%) 30.26%
Revenue growth, 5-year CAGR (12.95%) (39.74%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DBVT SLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.72 7.42 4.72
Net debt to EBITDA 1.35 0.94 0.96

Dividend

Metric DBVT SLN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DBVT SLN Biotechnology median
Market cap 572.56m 581.10m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack